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Abstract To clarify the fate of glycosylphosphatidylinositol
(GPI) in mammals, we developed GPI-anchored enhanced green
fluorescent protein (EGFP-GPI) and transgenic mice carrying
this fusion construct. When it was introduced to culture cells, the
EGFP-GPI protein was correctly sorted to plasma membranes
and microsomes depending on GPI biosynthesis. Transgenic mice
carrying EGFP-GPI were found to show a broad transgene
expression. Histologically, a prominent polarized localization of
EGFP-GPI protein was observed in various epithelia, the nervous
system and liver and secreted from some exocrine glands, as well
as non-polarized presence in non-epithelial tissues, demonstrating
a tissue-inherent manner of GPI sorting.
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1. Introduction
Numerous membrane proteins in eukaryotes are trans-
ported and attached to the plasma membrane via a glycosyl-
phosphatidylinositol (GPI)-anchor [1^3]. De¢cient GPI bio-
synthesis in hematopoietic cells causes paroxymal nocturnal
hemoglobinuria, demonstrating dysfunction of GPI associated
with human disease [4]. Previously, to elucidate the roles of
GPI in mammals, knockout experiments were performed and
found that the GPI system plays crucial roles in embryogen-
esis and keratinocyte di¡erentiation [5,6]. Recently, the mo-
saic mice for disrupting GPI biosynthesis were produced and
the extreme di¡erences in GPI requirements among tissues
were shown [7]. These results prompted us to investigate the
fate of GPI in global tissue and here, we developed transgenic
mice carrying GPI-anchored green £uorescent protein (GFP)
as an indicator [8,9].
Generally, GPI-anchored proteins are synthesized as pre-
cursors which contain two signal sequences: the amino-termi-
nal signal sequence for membrane translocation into the en-
doplasmic reticulum (ER) and the carboxy-terminal GPI-
anchor signal polypeptide [2,3]. Both signal peptides are
cleaved soon after translocation into the ER lumen and then,
the carboxy-terminal of the protein is covalently attached to
GPI which has been pre-synthesized en bloc in the ER. For
our purpose, the amino-terminal signal sequence of the sperm
secretory protein acrosin and the carboxy-terminal GPI-an-
chor signal sequence of Thy-1 were fused to either end of
enhanced GFP (EGFP). Here, we report the development of
EGFP-GPI and characterization of EGFP-GPI transgenic
mice.
2. Materials and methods
2.1. Generation of EGFP-GPI fusion gene
The EGFP was ¢rst fused with the membrane translocation signal
sequence of acrosin at the amino-terminal as described previously [10].
The acrosin-EGFP fusion DNA fragment was further ligated to the
5P-end of the mouse Thy-1 GPI-anchoring sequence. The amino acid
residue for GPI attachment (g site) was changed from cysteine to
asparagine for a more e⁄cient attachment (K. Ohishi, personal com-
munication). According to both gene linkages, additional 14 amino
acid sequences (KDNTTLQEFAT and LEN) would be resided in the
mature EGFP-GPI protein. Then, this fusion gene was ligated down
stream of the CAAG promoter, an established strong and broad driv-
ing element containing the cytomegalovirus immediate-early enhancer
and chicken L-actin promoter [11].
2.2. Cell culture and transfection
F9 and COS7 cells were cultured in DMEM supplemented with
10% FCS. For DNA transfection, lipofectamine reagents (Life Tech-
nologies, Rockville, MD, USA) were used according to the manufac-
turer’s protocol.
2.3. Phosphatidylinositol-speci¢c phospholipase C (PI-PLC) treatment
COS7 cells transfected with EGFP-GPI were treated with 2 IU/ml
of PI-PLC (Boehringer Mannheim, Mannheim, Germany) in DMEM
for 1 h at 37‡C. The incubated supernatant from each dishes was
collected, the £uorescent activity was measured at 488 nm excitation
and 518 nm emission wave lengths by a £uorometer and the total
protein was precipitated with 10% trichloroacetate, washed with
cold acetone and subjected to Western blotting.
2.4. Western blotting
Cells and tissues were ¢rst homogenized in TNE solution (10 mM
Tris-HCl pH 7.8, 1 mM EDTA, 150 mM NaCl) with Complete pro-
tease inhibitor (Boehringer Mannheim, Mannheim, Germany) at an
ice cold temperature. The homogenates were centrifuged at
100 000Ug. The supernatants were collected and stocked (the water-
soluble fraction). The precipitates were washed with TNE bu¡er and
then homogenized in 1% Triton X-114 (Nacalai tesque, Kyoto, Ja-
pan)-TNE solution with Complete protease inhibitor and centrifuged
at 100 000Ug. The supernatants were collected and stocked (the de-
tergent-soluble fraction). Both fractions of each tissue were subjected
to SDS-PAGE and electrophoretically transferred to a nitrocellulose
membrane. The membrane was probed with rabbit polyclonal anti-
body against GFP (MBL, Nagoya, Japan) and staining was detected
with ECL system-conjugated anti-rabbit IgG (Amersham Pharmacia
Biotech, Buckinghamshire, UK).
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2.5. Subcellular fractionation
COS7 cells transfected with EGFP-GPI were mechanically scraped
o¡ the culture dish. To prepare the membrane fraction, we followed
the methods of Koizumi et al. [12]. Brie£y, cells were suspended in
0.5 mM CaCl2 in 1.0 mM NaHCO3 bu¡er to prepare the cell ghost
and applied to a serial sucrose gradient centrifuge (42-68% sedimen-
tation and 42-48-68% sedimentation). To prepare cytoplasmic and
microsome fractions, we followed the methods of Hogeboom et al.
[13]. Brie£y, cells were suspended in 0.25 M sucrose-TKM (20 mM
Tris, pH 7.6, 50 mM KCl, 2 mM MgCl2) solution and homogenized.
Lysates were serially centrifuged at 1000, 12 000 and 105 000Ug. The
supernatants (cytoplasmic fraction) and precipitates (microsome frac-
tion) of the ¢nal centrifuge were collected and stocked. The method
for preparing the nuclear fraction was described before [14]. Brie£y,
cells were homogenized in 0.25 M sucrose-TKM solution. The ho-
mogenate was overlaid on 2.4 M sucrose-TKM solution and
centrifuged for 30 min at 14 000Ug. The precipitates (nuclear frac-
tion) were collected and sonicated. All fractions were ¢nally dissolved
in 1% Triton X-114-TNE solution and subjected to Western blotting.
2.6. Transgenic mouse production
The CAAG-EGFP-GPI transgene was injected into one-cell em-
bryos of B6C3F1 mice. By screening 42 newborn mice, we obtained
six transgenic founders and established three transgenic lineages (lines
1^3), all of which transmitted the transgene in a Mendelian fashion.
2.7. Histological analyses
Mice were deeply anesthetized with phenobarbital and ¢xed by
perfusing with 4% (w/v) paraformaldehyde-PBS via the left ventricle
of the heart. Excised tissues were ¢xed again in 4% paraformaldehyde-
PBS and then incubated in 20% sucrose-PBS for 48 h at 4‡C. Pieces of
tissues were then embedded in Tissue-Tek O.C.T. compound (Sakura
Finetek, Torrance, CA, USA), quickly frozen with dry ice and sec-
tioned on a cryostat in 5^10 Wm thicknesses. Preparations were exam-
ined by £uorescence microscopy with GFP-speci¢ed ¢lters (Olympus,
Tokyo, Japan).
3. Results and discussion
3.1. Characterization of EGFP-GPI in culture cells
When the EGFP-GPI fusion construct was stably expressed
in F9 cells, a marked green £uorescence was detected on the
plasma membrane and in intracellular structures, which was
quite di¡erent from the original EGFP transfectants (Fig.
1A). The intracellular structure was identi¢ed as a Golgi com-
plex by co-staining with wheat germ agglutinin (data not
shown). To compare both EGFP molecules further, Western
blotting was performed and showed that EGFP-GPI was
about 4 kDa larger than EGFP (31 versus 27 kDa), which
almost corresponds to the sum of GPI plus the additional 14
amino acid molecular weights (s 3800 Da). Moreover, the
EGFP-GPI molecule was e¡ectively solubilized when deter-
gent was added to the lysis bu¡er, while the original EGFP
was e¡ectively extracted without detergent. These ¢ndings
suggest that EGFP-GPI contains a highly hydrophobic moi-
ety.
Fig. 1. Expression and characterization of EGFP-GPI in culture cells. (A) Stable expression of EGFP-GPI in F9 cells. Upper panels, £uores-
cence microscopic views. Middle panels, phase-contrast views. Lower panel, Western blotting. Tx-114 +, detergent-plus lysis bu¡er; Tx-114 3,
detergent-minus lysis bu¡er. (B) Release of EGFP-GPI by PI-PLC cleavage. Upper panels, £uorescence microscopic views. Middle panels,
phase-contrast views. Lower panel left, £uorescence of culture supernatants. Means after background subtraction with an S.D. bar are indi-
cated. Lower panel right, Western blotting. Spontaneous release of EGFP-GPI was observed in both assays. PI-PLC (+), PI-PLC treated; PI-
PLC (3), PI-PLC non-treated; v, vector-transfected cells. (C) Subcellular fractionation of EGFP-GPI transfectants. Western blotting. Whole,
cell lysate without fractionation. Membrane, plasma membrane.
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To con¢rm that EGFP-GPI was anchored via GPI, sensi-
tivity to PI-PLC was tested. It is well-known that PI-PLC
cleaves the GPI phosphate-glycerol bond and releases GPI-
anchored protein from the membrane to the water-soluble
phase, which is a useful diagnostic tool for con¢rming GPI-
anchorage of the protein [15]. Bacterial PI-PLC was added to
the culture medium of EGFP-GPI-transfected COS7 cells. In
the presence of PI-PLC, membranous £uorescence was dimin-
ished. In proportion to this, total £uorescence of culture
supernatants was increased and elevation of EGFP-GPI in
the supernatant was detected by Western blotting (Fig. 1B).
We also observed membrane attachment of EGFP-GPI in
GPI-anchor positive cells, but not in GPI-anchor negative
counterparts (data not shown). These ¢ndings demonstrate
that EGFP-GPI is attached to the outer surface of plasma
membranes by GPI.
To elucidate the e¡ects of fused peptides and over-expres-
sion, which would cause mis-localization of EGFP-based fu-
sion protein, subcellular fractionation was performed. The
lysates of COS7 cells transfected with EGFP-GPI were frac-
tionated and subjected to Western blotting. Even in extreme
over-expression conditions using the SV40 replicative system
in COS cells, EGFP-GPI was solely fractionated to the plas-
ma membrane and microsomes where GPI-anchored proteins
are harbored, suggesting that peptide fusion and over-expres-
sion have no e¡ects on the sorting of EGFP-GPI (Fig. 1C).
3.2. Development of EGFP-GPI transgenic mouse
To clarify the fate of GPI in vivo, transgenic mice carrying
an EGFP-GPI fusion construct were raised. All transgenic
mice were born normal size, had no morphological abnormal-
ities and were fertile. The expression of transgene mRNA was
¢rst examined and widely detected in tissues (data not shown).
Expression of EGFP-GPI protein was then examined in
various tissues. Both water-soluble and detergent-soluble frac-
tions of each tissue were subjected to Western blotting. As
shown in Fig. 2A, EGFP-GPI protein was solubilized in
both fractions, but to di¡erent degrees in each tissue. In tis-
sues like brain, heart, liver, spleen and testes, most of the
EGFP-GPI was solubilized in detergent-plus bu¡er. In con-
trast, large amounts of EGFP-GPI were solubilized in water-
soluble as well as detergent-soluble fractions in pancreas and
seminal vesicles. Histologically, strong homogeneous £uores-
cence in the secretory duct of pancreas and the plasma of
seminal vesicles was observed (Fig. 2B), suggesting that
EGFP-GPI was abundantly released here. It was previously
reported that secretion of GP-2 and CDw52, kinds of the
GPI-anchored proteins, were noted in rat pancreatic acinar
cells and human seminal plasma, respectively [16,17]. Our
¢ndings may support these observations.
3.3. Histological survey of EGFP-GPI transgenic mice
Fixed tissues were sectioned frozen and immediately exam-
ined by £uorescence microscopy. Localization of EGFP-GPI
protein could be classi¢ed as polarized/localized or non-polar-
ized. All kinds of epithelial cells showed polarized localization
of EGFP-GPI. The presence in representative tissues, such as
pancreatic acinar cells, intestinal pinoepithelium, transitional
epithelium of the urinary bladder and seminal epithelium, is
shown (Fig. 3A^D). These appearances were similar to those
of some endogenous GPI-anchored proteins, such as N-CAM
in intestinal pinoepithelium and GP-2 in pancreatic acinus
[16,18]. We also observed EGFP-GPI apical localization in
the transitional and squamous epithelia (X.-H. Gao, unpub-
lished data), suggesting that the apical polarization of GPI-
anchored proteins is a more general phenotype among epithe-
Fig. 2. Expression of EGFP-GPI in various tissues of EGFP-GPI transgenic mice. (A) Expression of EGFP-GPI protein in multiple organs.
Western blotting. Tx-114 +, detergent-plus lysis bu¡er; Tx-114 3, detergent-minus lysis bu¡er. (B) The £uorescent histology of pancreas and
seminal vesicle. Magni¢cation: pancreas, U200; seminal vesicle, U100. F9, F9 transfectants; Br, brain; Hr, heart; Li, liver; Sp, spleen; Te, tes-
tis ; Pa, pancreas; Sv, seminal vesicle; id, intercalated duct; sd, secretory duct; ac, acinus; sp, seminal plasma. The presenting results were ob-
tained from a line 3 transgenic mouse.
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lia despite of their morphology and distribution. In the nerv-
ous system, EGFP-GPI was speci¢cally localized in nerve ¢-
bers (Fig. 3E). For instance, ¢ne £uorescence could be seen on
nerve ¢bers, but not on perikaryons, in the local neural net-
works of retina, suggesting that the mature GPI molecules
were constitutively produced here, sorting and anchoring
GPI-anchored proteins to nerve ¢bers. In the liver, EGFP-
GPI seemed to localize along the network of bile canaliculi
(Fig. 3F). This pattern of expression is similar to alkaline
phosphatase and 5P-nucleotidase, a well-known GPI-anchored
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protein speci¢cally localized to bile canaliculi [19,20], demon-
strating that the expression of EGFP-GPI faithfully represents
endogenous GPI-anchored protein. However, the expression
of alkaline phosphatase in EGFP-GPI transgenic mice was
reduced in comparison with wild-type mice (data not shown),
suggesting that the amount of GPI is quite limited here. As
bile canaliculi are composed of the plasma membrane of liver
parenchymal cells, they might correspond to apical surfaces of
the epithelium and GPI may speci¢cally act as an intracellular
sorting apparatus in the liver parenchymal cells. In contrast to
these observations, non-epithelial cells, such as muscle cells,
mesenchymal cells, hematopoietic cells and vascular endothe-
lial cells, showed non-polarized localization, comparable with
EGFP-GPI transfectants (Fig. 3G^I).
For labelling cell surfaces, EGFP-GPI might be applicable
to many eukaryote systems, including primitive protozoa and
yeast, because it is processed and targeted to the plasma mem-
brane via the ubiquitous GPI-anchoring system. Another ben-
e¢t of EGFP-GPI is that it is fully exposed to the cell surface.
This means that EGFP-GPI could be used as an immuno
target for antibody-mediated collection or elimination of tar-
get cells. Moreover, as ¢ne £uorescence was detected along
networks of nerve ¢bers and bile canaliculi, it might be a
simple way of visualizing these structures under physiological
and pathological conditions.
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Fig. 3. Fluorescent histology of EGFP-GPI transgenic mice. (A) Pancreas. Bright £uorescence can be seen on the apical side of acinar cells, fol-
lowed by intercellular secretory canaliculi (sc). ac, acinus; id, intercalated duct. Magni¢cation, U200. (B) Duodenum. Bright £uorescence was
markedly localized to the apical side of pinoepithelial cells (pe). Magni¢cation, U400. (C) Urinary bladder. Apparent apical polarization of £u-
orescence can be seen on transitional epithelium (te). mc, tunica propria mucosae. Magni¢cation, U400. (D) Seminal vesicle. Apical but not
basal localization of £uorescence can be seen on seminal epithelium (se). sp, seminal plasma; cp, capsular smooth muscle cells. Magni¢cation,
U400. (E) Retina. Bright £uorescence can be seen on nerve ¢ber-rich layers and, reciprocally, £uorescence-lucent areas correspond to the peri-
karyon-rich layers. Worm-like structures are blood vessels. on, optic ganglion cell layer; ip, inner plexiform layer; ig, inner granular layer; op,
outer plexiform layer; og, outer granular layer; r and c, rod and cone layer; pc, pigment cell layer. Magni¢cation, U200. (F) Liver. Bright £u-
orescence can be seen along the bile canaliculi network. cv, central vein. Magni¢cation, U200. (G) Skeletal muscle. Muscle ¢bers (mf) are sur-
rounded by strong homogeneous £uorescence. v, blood vessel. Magni¢cation, U200. (H) Renal corpuscle. Strong homogeneous £uorescence on
mesangium cells (mc) of gromerulus can be seen. Bc, Bowman’s capsule; aa, arteriola a¡erense. Magni¢cation, U400. (I) Spleen. Strong homo-
geneous £uorescence can be seen on the membrane of splenocytes (sc). Magni¢cation, U200. Arrowheads in B^D indicate the apical side of
each organ and in E, they indicate perikaryons of optic ganglion cells. The presenting results were obtained from a line 3 transgenic mouse.
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